Form 4: Ardent Health Partners Director Suzanne Campion Reports Stock Transactions

Director Suzanne Campion reports acquisition and disposal of Ardent Health Partners common stock and restricted stock units.

Summary

• On March 21, 2025, Suzanne Campion, a director of Ardent Health Partners, engaged in transactions involving the company's stock.
• Campion acquired 12,916 shares of common stock at $0.
• Campion disposed of 12,916 shares of common stock.
• Following these transactions, Campion beneficially owns 43,984 shares of Ardent Health Partners common stock.
• Campion also holds restricted stock units that vest on the first anniversary of March 21, 2025, contingent upon continued service with the issuer.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.

Future Outlook

The restricted stock units will vest on March 21, 2026, contingent upon the Reporting Person's continued service with the Issuer.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.

Key Dates

Keywords

Ardent Health Partners, Director, Stock Transactions, Beneficial Ownership, Restricted Stock Units, Form 4, ARDT